BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8075027)

  • 21. [Clinicopathologic features of 66 cases of anaplastic lymphoma kinase positive and negative systemic anaplastic large cell lymphoma: a comparative study].
    Shi Y; Chen G; Zhou XG; Gong LP; Yu R; Zheng YY; Xie JL; Jin Y
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):235-9. PubMed ID: 20654121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD56 expression in a case of primary cutaneous CD30+ anaplastic large cell lymphoma.
    Chang SE; Park IJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
    Br J Dermatol; 2000 Apr; 142(4):766-70. PubMed ID: 10792229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature.
    Burg G; Kempf W; Kazakov DV; Dummer R; Frosch PJ; Lange-Ionescu S; Nishikawa T; Kadin ME
    Br J Dermatol; 2003 Mar; 148(3):580-6. PubMed ID: 12653754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaplastic large cell lymphoma (CD30+/Ki-1+). Analysis of 35 cases followed at GISL centres.
    Longo G; Federico M; Pieresca C; Avanzini P; Iannitto E; Di Prisco AU; Baldini L; Brugiatelli M; Clò V; Bevini M
    Eur J Cancer; 1995 Oct; 31A(11):1763-7. PubMed ID: 8541096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexistence of CD30-positive anaplastic large cell lymphoma and mycosis fungoides.
    Kang SK; Chang SE; Choi JH; Sung KJ; Moon KC; Koh JK
    Clin Exp Dermatol; 2002 May; 27(3):212-5. PubMed ID: 12072011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaplastic large cell lymphoma--a rare disorder in southern Taiwan.
    Lin CN; Hou CC; Hwang WS; Chuang SS
    Leuk Lymphoma; 2003 Oct; 44(10):1727-31. PubMed ID: 14692525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary cutaneous CD30-positive anaplastic large cell lymphoma].
    Shi Q; Xu X; Yin H; Zhou X; Zhang T; Sun G; Mikihiro S; Qian B
    Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):97-100. PubMed ID: 11866962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of mycosis fungoides after CD30 positive anaplastic large cell lymphoma.
    Lee MW; Chi DH; Choi JH; Sung KJ; Moon KC; Koh JK
    J Dermatol; 2000 Jul; 27(7):458-61. PubMed ID: 10935344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should primary cutaneous Ki-1(CD30)-positive anaplastic large cell lymphoma in childhood be treated with multiple-agent chemotherapy?
    Vermeer MH; Bekkenk MW; Willemze R
    J Am Acad Dermatol; 2001 Oct; 45(4):638-40. PubMed ID: 11568767
    [No Abstract]   [Full Text] [Related]  

  • 30. Anaplastic large cell (CD30/Ki-1+) lymphoma in HIV+ patients: clinical and pathological findings in a group of ten patients.
    Nosari A; Cantoni S; Oreste P; Schiantarelli C; Landonio G; Alexiadis S; Gargantini L; Caggese L; Gambacorta M; Morra E
    Br J Haematol; 1996 Dec; 95(3):508-12. PubMed ID: 8943892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.
    Liu HL; Hoppe RT; Kohler S; Harvell JD; Reddy S; Kim YH
    J Am Acad Dermatol; 2003 Dec; 49(6):1049-58. PubMed ID: 14639383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaplastic large cell lymphoma (CD30 +/Ki-1+): results of a prospective clinico-pathological study of 69 cases.
    Pileri S; Bocchia M; Baroni CD; Martelli M; Falini B; Sabattini E; Gherlinzoni F; Amadori S; Poggi S; Mazza P
    Br J Haematol; 1994 Mar; 86(3):513-23. PubMed ID: 7519036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype.
    de Bruin PC; Beljaards RC; van Heerde P; Van Der Valk P; Noorduyn LA; Van Krieken JH; Kluin-Nelemans JC; Willemze R; Meijer CJ
    Histopathology; 1993 Aug; 23(2):127-35. PubMed ID: 8406384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
    Oregel KZ; Everett E; Zhang X; Nagaraj G
    Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A clinico-pathological and immunohistochemical study on anaplastic large cell lymphoma].
    Jin X; Li C; Ding C; Chu Q
    Zhonghua Bing Li Xue Za Zhi; 1999 Jun; 28(3):194-6. PubMed ID: 11869528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35).
    Bitter MA; Franklin WA; Larson RA; McKeithan TW; Rubin CM; Le Beau MM; Stephens JK; Vardiman JW
    Am J Surg Pathol; 1990 Apr; 14(4):305-16. PubMed ID: 2157342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nervous system involvement at diagnosis in a case of pediatric CD30+ anaplastic large cell lymphoma.
    Kaplinsky C; Toren A; Neumann Y; Mandel M; Kenet G; Sharon N; Rechavi G; Biniaminov M; Rubanov V; Rosenthal E; Rosner E; Mark Z; Amariglio N; Brok-Simoni F
    Med Pediatr Oncol; 1997 Feb; 28(2):132-5. PubMed ID: 8986149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of anaplastic large-cell lymphoma, including multifocal osseous KI-1 lymphoma, by fine-needle aspiration biopsy.
    Liu K; Dodd LG; Osborne BM; Martinez S; Olatdioye BA; Madden JF
    Diagn Cytopathol; 1999 Sep; 21(3):174-9. PubMed ID: 10450102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solitary primary cutaneous CD30+ large cell lymphoma of natural killer cell phenotype bearing the t(2;5)(p23;q35) translocation and presenting in a child.
    Gould JW; Eppes RB; Gilliam AC; Goldstein JA; Mikkola DL; Zaim MT; Wood GS
    Am J Dermatopathol; 2000 Oct; 22(5):422-8. PubMed ID: 11048978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD30 antigen in non-Hodgkin's lymphoma.
    Miyake K; Yoshino T; Sarker AB; Teramoto N; Akagi T
    Pathol Int; 1994 Jun; 44(6):428-34. PubMed ID: 8055109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.